Masimo Corporation (MASI) Receiving Somewhat Positive Press Coverage, Analysis Finds

Headlines about Masimo Corporation (NASDAQ:MASI) have been trending somewhat positive on Saturday, Alpha One Sentiment reports. The research group, a service of Accern, identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Masimo Corporation earned a news sentiment score of 0.12 on Alpha One’s scale. Alpha One also gave news coverage about the medical equipment provider an impact score of 65 out of 100, meaning that recent press coverage is somewhat likely to have an impact on the stock’s share price in the near term.

Here are some of the media stories that may have effected AlphaOne’s analysis:

Insider Buying and Selling by Quarter for Masimo Corporation (NASDAQ:MASI)

A number of analysts have recently weighed in on the stock. Wedbush reaffirmed an “outperform” rating and issued a $95.00 price target on shares of Masimo Corporation in a research note on Monday, February 27th. Piper Jaffray Companies downgraded shares of Masimo Corporation from an “overweight” rating to a “neutral” rating in a report on Thursday, March 16th. Finally, Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 11th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $78.00.

Masimo Corporation (MASI) opened at 91.11 on Friday. Masimo Corporation has a 12 month low of $48.07 and a 12 month high of $104.71. The stock has a market capitalization of $4.66 billion, a P/E ratio of 15.47 and a beta of 0.89. The company’s 50-day moving average is $89.56 and its 200-day moving average is $83.01.

Masimo Corporation (NASDAQ:MASI) last issued its earnings results on Wednesday, May 3rd. The medical equipment provider reported $0.82 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.22. The firm had revenue of $186.30 million during the quarter, compared to the consensus estimate of $184.14 million. Masimo Corporation had a return on equity of 24.19% and a net margin of 44.86%. The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.53 earnings per share. Equities analysts anticipate that Masimo Corporation will post $2.66 earnings per share for the current year.

In other news, Director Sanford Fitch sold 3,000 shares of the business’s stock in a transaction dated Wednesday, March 22nd. The stock was sold at an average price of $93.23, for a total transaction of $279,690.00. Following the sale, the director now directly owns 80,000 shares in the company, valued at $7,458,400. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Raad Mark De sold 48,000 shares of the business’s stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $93.25, for a total value of $4,476,000.00. Following the sale, the chief financial officer now owns 14,660 shares in the company, valued at $1,367,045. The disclosure for this sale can be found here. In the last three months, insiders have sold 562,201 shares of company stock valued at $56,005,386. Insiders own 16.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with's FREE daily email newsletter.

Leave a Reply